Nalaganje...
Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece
BACKGROUND: Imiquimod 3.75% is a field‐directed treatment for actinic keratosis that can detect and treat clinical and subclinical lesions across an entire sun‐exposed field. The detection of subclinical lesions is evidenced by an increase in lesions to the maximum lesion count during treatment (L (...
Shranjeno v:
| izdano v: | Int J Dermatol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850341/ https://ncbi.nlm.nih.gov/pubmed/30779341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijd.14397 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|